Medicago, a biopharmaceutical company headquartered in Quebec City, announced today that they have successfully produced a Virus-Like Particle (VLP) of the coronavirus just 20 days after obtaining the SARS-CoV-2 (virus causing the COVID-19 disease) gene. Production of the VLP is the first step in developing a vaccine for COVID-19, which will now undergo preclinical testing for safety and efficacy. Once this is completed, Medicago expects to discuss with the appropriate Health Agencies to initiate human trials of the vaccine by summer (July/August) 2020.
Medicago is also using its technology platform to develop antibodies against SARS-CoV-2 in collaboration with the Laval University’s Infectious Disease Research Centre headed by Dr. Gary Kobinger, who helped develop a vaccine and treatment for Ebola. These SARS-CoV-2 antibodies could potentially be used to treat people infected by the virus. This research is being funded, in part, by the Canadian Institutes for Health Research (CIHR).
Medicago is a leader in plant-based technology, having previously demonstrated its capability to be a first responder in a flu pandemic. In 2009, the company produced a research-grade vaccine candidate against H1N1 in just 19 days. In 2012, Medicago manufactured 10 million doses of a monovalent influenza vaccine within one month for the Defense Advanced Research Projects Agency (DARPA), part of the U.S. Department of Defense. In 2015, Medicago also demonstrated that it could rapidly produce an anti-Ebola monoclonal antibody cocktail for the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services.
“The pace of our initial progress in COVID-19 is attributable to the capability of our plant-based platform, which is able to produce vaccine and antibody solutions to counteract this global public health threat. The ability to produce a candidate vaccine within 20 days after obtaining the gene is a critical differentiator for our proven technology. This technology enables scale-up at unprecedented speed to potentially combat COVID-19,” said Dr. Bruce Clark, CEO of Medicago.
Dr. Gary Kobinger, Professor in the Department of Microbiology and Infectious Diseases and the Director of the Infectious Disease Research Centre at Laval University, said “The collaborative efforts established between the research team at Laval University and Medicago have been very successful in developing unique antibodies against infectious diseases such as RSV and HMPV, and that experience gives us confidence for successful identification of therapeutic antibodies against SARS-CoV-2.”
Medicago’s first product, a seasonal recombinant quadrivalent VLP vaccine for active immunization against influenza, is currently under review by Health Canada following the completion of a robust safety and efficacy clinical program involving over 25,000 patients.
On 12 May 2020 the Chișinău Appeals Court barred Danube Logistics SRL from transferring funds to its Dutch shareholder Danube Logistics Holding BV. Danube Logistics SRL is the operator of Giurgiulești International Free Port located on the maritime section of the Danube.( ) Read all
On the building that once housed the local headquarters of the Soviet secret police in the Russian city of Tver, where 80 years ago thousands of Polish prisoners of war were murdered, plaques commemorating the victims of Stalinist crimes were today removed.( ) Read all
That is the message the country's Constitutional Court sent to the European Union on Tuesday as it delivered a landmark ruling on the legality of the European Central Bank’s bond-buying programs, a decision many observers say challenges both the independence of the ECB and the...( ) Read all
The cost of a three-course meal at Bord For En (Table For One), a pop-up restaurant in Sweden opening May 10, is left to the diner's discretion. And that is diner, singular, just like the restaurant's name suggests.( ) Read all
A new virus, SARS-CoV-2, emerged in the Chinese city of Wuhan at the end of 2019. Infected persons developed an atypical form of pneumonia, later known as COVID-19. The pathogen created a pandemic, with fatalities throughout the world, and also led to the adoption of restrictive measures...( ) Read all
The two powers amplify discredited conspiracy theories and sow division as they look to undermine the United States. China and Russia have both seized on the novel coronavirus to wage disinformation campaigns that seek to sow doubts about the United States’ handling of the crisis and...( ) Read all
Opinion polls and authoritarian systems don’t go together. However professional or independent the pollster, any results are necessarily skewed as people weigh their responses — especially to questions about the regime — against potential consequences. Political scientists...( ) Read all
The 15-year-old boy from the Yanomami indigenous tribe lived in a remote village such as this one. (CNN) A teenager from an isolated Amazonian tribe who tested positive for Covid-19 has died, raising concerns about the coronavirus' impact on the region's indigenous people.( ) Read all
(CNN)The body of Maeve Kennedy Townsend McKean has been found by divers, police said. Members of a dive and rescue team found the body in 25 feet of water, about 2.5 miles from her mother's residence, around 5:31 p.m. Monday, the Maryland Natural Resources Police said in a statement.( ) Read all
Spain has recorded another 864 deaths related to coronavirus, the highest in one day, as the total number of deaths across Europe has gone beyond 30,000. More than 9,000 people have died in Spain, which is second only to Italy in fatalities caused by the virus. Confirmed cases in the country...( ) Read all
A 13-year-old boy who tested positive for coronavirus has died, a London hospital trust has said. Ismail Mohamed Abdulwahab, from Brixton in south London, died in King's College Hospital early on Monday. He is thought to be the youngest person to have died with the virus in the UK.( ) Read all
An elderly Catholic priest reportedly died from the COVID-19 coronavirus after refusing a ventilator so that a younger patient could use it instead. Don Giuseppe Berardelli, 72, died March 15 at a hospital in Lovere, Italy after declining to use the medical equipment that his parishioners were...( ) Read all